{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:06:22Z","timestamp":1793829982321,"version":"4.6.1"},"reference-count":193,"publisher":"American Diabetes Association","issue":"5","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,5,1]]},"abstract":"<jats:p>Diabetic autonomic neuropathy (DAN) is a serious and common complication of diabetes. Despite its relationship to an increased risk of cardiovascular mortality and its association with multiple symptoms and impairments, the significance of DAN has not been fully appreciated. The reported prevalence of DAN varies widely depending on the cohort studied and the methods of assessment. In randomly selected cohorts of asymptomatic individuals with diabetes, \u223c20% had abnormal cardiovascular autonomic function. DAN frequently coexists with other peripheral neuropathies and other diabetic complications, but DAN may be isolated, frequently preceding the detection of other complications. Major clinical manifestations of DAN include resting tachycardia, exercise intolerance, orthostatic hypotension, constipation, gastroparesis, erectile dysfunction, sudomotor dysfunction, impaired neurovascular function, \u201cbrittle diabetes,\u201d and hypoglycemic autonomic failure. DAN may affect many organ systems throughout the body (e.g., gastrointestinal [GI], genitourinary, and cardiovascular). GI disturbances (e.g., esophageal enteropathy, gastroparesis, constipation, diarrhea, and fecal incontinence) are common, and any section of the GI tract may be affected. Gastroparesis should be suspected in individuals with erratic glucose control. Upper-GI symptoms should lead to consideration of all possible causes, including autonomic dysfunction. Whereas a radiographic gastric emptying study can definitively establish the diagnosis of gastroparesis, a reasonable approach is to exclude autonomic dysfunction and other known causes of these upper-GI symptoms. Constipation is the most common lower-GI symptom but can alternate with episodes of diarrhea. Diagnostic approaches should rule out autonomic dysfunction and the well-known causes such as neoplasia. Occasionally, anorectal manometry and other specialized tests typically performed by the gastroenterologist may be helpful. DAN is also associated with genitourinary tract disturbances including bladder and\/or sexual dysfunction. Evaluation of bladder dysfunction should be performed for individuals with diabetes who have recurrent urinary tract infections, pyelonephritis, incontinence, or a palpable bladder. Specialized assessment of bladder dysfunction will typically be performed by a urologist. In men, DAN may cause loss of penile erection and\/or retrograde ejaculation. A complete workup for erectile dysfunction in men should include history (medical and sexual); psychological evaluation; hormone levels; measurement of nocturnal penile tumescence; tests to assess penile, pelvic, and spinal nerve function; cardiovascular autonomic function tests; and measurement of penile and brachial blood pressure. Neurovascular dysfunction resulting from DAN contributes to a wide spectrum of clinical disorders including erectile dysfunction, loss of skin integrity, and abnormal vascular reflexes. Disruption of microvascular skin blood flow and sudomotor function may be among the earliest manifestations of DAN and lead to dry skin, loss of sweating, and the development of fissures and cracks that allow microorganisms to enter. These changes ultimately contribute to the development of ulcers, gangrene, and limb loss. Various aspects of neurovascular function can be evaluated with specialized tests, but generally these have not been well standardized and have limited clinical utility. Cardiovascular autonomic neuropathy (CAN) is the most studied and clinically important form of DAN. Meta-analyses of published data demonstrate that reduced cardiovascular autonomic function as measured by heart rate variability (HRV) is strongly (i.e., relative risk is doubled) associated with an increased risk of silent myocardial ischemia and mortality. The determination of the presence of CAN is usually based on a battery of autonomic function tests rather than just on one test. Proceedings from a consensus conference in 1992 recommended that three tests (R-R variation, Valsalva maneuver, and postural blood pressure testing) be used for longitudinal testing of the cardiovascular autonomic system. Other forms of autonomic neuropathy can be evaluated with specialized tests, but these are less standardized and less available than commonly used tests of cardiovascular autonomic function, which quantify loss of HRV. Interpretability of serial HRV testing requires accurate, precise, and reproducible procedures that use established physiological maneuvers. The battery of three recommended tests for assessing CAN is readily performed in the average clinic, hospital, or diagnostic center with the use of available technology. Measurement of HRV at the time of diagnosis of type 2 diabetes and within 5 years after diagnosis of type 1 diabetes (unless an individual has symptoms suggestive of autonomic dysfunction earlier) serves to establish a baseline, with which 1-year interval tests can be compared. Regular HRV testing provides early detection and thereby promotes timely diagnostic and therapeutic interventions. HRV testing may also facilitate differential diagnosis and the attribution of symptoms (e.g., erectile dysfunction, dyspepsia, and dizziness) to autonomic dysfunction. Finally, knowledge of early autonomic dysfunction can encourage patient and physician to improve metabolic control and to use therapies such as ACE inhibitors and \u03b2-blockers, proven to be effective for patients with CAN.<\/jats:p>","DOI":"10.2337\/diacare.26.5.1553","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T17:51:27Z","timestamp":1173117087000},"page":"1553-1579","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1571,"title":["Diabetic Autonomic Neuropathy"],"prefix":"10.2337","volume":"26","author":[{"given":"Aaron I.","family":"Vinik","sequence":"first","affiliation":[{"name":"Strelitz Diabetes Research Institutes, Eastern Virginia Medical School, Norfolk, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raelene E.","family":"Maser","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, University of Delaware, Newark, Delaware"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Braxton D.","family":"Mitchell","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Freeman","sequence":"additional","affiliation":[{"name":"Center for Autonomic and Peripheral Nerve Disorders, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031216530761800_R1","doi-asserted-by":"crossref","unstructured":"Vinik AI, Erbas T: Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med\u200868:928\u2013944, 2001","DOI":"10.3949\/ccjm.68.11.928"},{"key":"2022031216530761800_R2","unstructured":"Freeman R: The peripheral nervous system and diabetes. In Joslin\u2019s Diabetes Mellitus. Weir G, Kahn R, King GL, Eds. Philadelphia, Lippincott, 2002"},{"key":"2022031216530761800_R3","doi-asserted-by":"crossref","unstructured":"American Diabetes Association and American Academy of Neurology: Report and recommendations of the San Antonio Conference on diabetic neuropathy (Consensus Statement). Diabetes\u200837:1000\u20131004, 1988","DOI":"10.2337\/diab.37.7.1000"},{"key":"2022031216530761800_R4","unstructured":"Ziegler D: Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Reviews\u20087:300\u2013315, 1999"},{"key":"2022031216530761800_R5","doi-asserted-by":"crossref","unstructured":"Pfeifer MA, Weinberg CR, Cook DL, Reenan A, Halter JB, Ensinck JW, Porte D Jr: Autonomic neural dysfunction in recently diagnosed diabetic subjects. Diabetes Care\u20087:447\u2013453, 1984","DOI":"10.2337\/diacare.7.5.447"},{"key":"2022031216530761800_R6","doi-asserted-by":"crossref","unstructured":"Ewing DJ: Cardiovascular reflexes and autonomic neuropathy. Clin Sci Mol Med\u200855:321\u2013327, 1978","DOI":"10.1042\/cs0550321"},{"key":"2022031216530761800_R7","doi-asserted-by":"crossref","unstructured":"Clarke BF, Ewing DJ, Campbell IW: Diabetic autonomic neuropathy. Diabetologia\u200817:195\u2013212, 1979","DOI":"10.1007\/BF01235856"},{"key":"2022031216530761800_R8","doi-asserted-by":"crossref","unstructured":"Vinik AI: Diagnosis and management of diabetic neuropathy. Clin Geriatr Med\u200815:293\u2013320, 1999","DOI":"10.1016\/S0749-0690(18)30061-2"},{"key":"2022031216530761800_R9","doi-asserted-by":"crossref","unstructured":"Greene DA, Lattimer SA: Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest\u200872:1058\u20131063, 1983","DOI":"10.1172\/JCI111030"},{"key":"2022031216530761800_R10","doi-asserted-by":"crossref","unstructured":"Greene DA, Lattimer SA, Sima AA: Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes\u200837:688\u2013693, 1988","DOI":"10.2337\/diabetes.37.6.688"},{"key":"2022031216530761800_R11","doi-asserted-by":"crossref","unstructured":"Veves A, King GL: Can VEGF reverse diabetic neuropathy in human subjects? J Clin Invest\u2008107:1215\u20131218, 2001","DOI":"10.1172\/JCI13038"},{"key":"2022031216530761800_R12","doi-asserted-by":"crossref","unstructured":"Cameron NE, Cotter MA: Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes\u200846(Suppl. 2):31S\u201337S, 1997","DOI":"10.2337\/diab.46.2.S31"},{"key":"2022031216530761800_R13","doi-asserted-by":"crossref","unstructured":"Low PA, Nickander KK, Tritschler HJ: The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes\u200846(Suppl. 2):S38\u2013S42, 1997","DOI":"10.2337\/diab.46.2.S38"},{"key":"2022031216530761800_R14","doi-asserted-by":"crossref","unstructured":"Hoeldtke RD, Bryner KD, McNeill DR, Hobbs GR, Riggs JE, Warehime SS, Christie I, Ganser G, Van Dyke K: Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes\u200851:2817\u20132825, 2002","DOI":"10.2337\/diabetes.51.9.2817"},{"key":"2022031216530761800_R15","doi-asserted-by":"crossref","unstructured":"Vinik AI, Erbas T, Tae S, Stansberry K, Scanelli JA, Pittenger GL: Dermal neurovascular dysfunction in type 2 diabetes. Diabetes Care\u200824:1468\u20131475, 2001","DOI":"10.2337\/diacare.24.8.1468"},{"key":"2022031216530761800_R16","doi-asserted-by":"crossref","unstructured":"Pittenger GL, Malik RA, Burcus N, Boulton AJ, Vinik AI: Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes. Diabetes Care\u200822:1839\u20131844, 1999","DOI":"10.2337\/diacare.22.11.1839"},{"key":"2022031216530761800_R17","unstructured":"Vinik AI, Pittenger GL, Milicevic Z, Knezevic-Cuca J: Autoimmune mechanisms in the pathogenesis of diabetic neuropathy. In Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. Eisenbarth G, Ed. Austin, TX, R.G. Landes, 1999, p. 217\u2013251"},{"key":"2022031216530761800_R18","doi-asserted-by":"crossref","unstructured":"Sundkvist G, Lind P, Bergstrom B, Lilja B, Rabinowe SL: Autonomic nerve antibodies and autonomic nerve function in type 1 and type 2 diabetic patients. J Intern Med\u2008229:505\u2013510, 1991","DOI":"10.1111\/j.1365-2796.1991.tb00386.x"},{"key":"2022031216530761800_R19","doi-asserted-by":"crossref","unstructured":"Apfel SC, Arezzo JC, Brownlee M, Federoff H, Kessler JA: Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res\u2008634:7\u201312, 1994","DOI":"10.1016\/0006-8993(94)90252-6"},{"key":"2022031216530761800_R20","doi-asserted-by":"crossref","unstructured":"Horrobin DF: Essential fatty acids in the management of impaired nerve function in diabetes. Diabetes\u200846(Suppl. 2):S90\u2013S93, 1997","DOI":"10.2337\/diab.46.2.S90"},{"key":"2022031216530761800_R21","doi-asserted-by":"crossref","unstructured":"Brownlee M: Glycation products and the pathogenesis of diabetic complications. Diabetes Care\u200815:1835\u20131843, 1992","DOI":"10.2337\/diacare.15.12.1835"},{"key":"2022031216530761800_R22","doi-asserted-by":"crossref","unstructured":"Obrosova IG: How does glucose generate oxidative stress in peripheral nerve? Intern Review Neurobiology\u200850:3\u201335, 2002","DOI":"10.1016\/S0074-7742(02)50071-4"},{"key":"2022031216530761800_R23","doi-asserted-by":"crossref","unstructured":"Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabo E, Szabo C: The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes. Diabetes\u200851:514\u2013521, 2002","DOI":"10.2337\/diabetes.51.2.514"},{"key":"2022031216530761800_R24","doi-asserted-by":"crossref","unstructured":"Ziegler D, Gries FA, Spuler M, Lessmann F, Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group: The epidemiology of diabetic neuropathy. J Diabetes Complications\u20086:49\u201357, 1992","DOI":"10.1016\/1056-8727(92)90049-Q"},{"key":"2022031216530761800_R25","doi-asserted-by":"crossref","unstructured":"Kennedy WR, Navarro X, Sutherland DER: Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology\u200845:773\u2013780, 1995","DOI":"10.1212\/WNL.45.4.773"},{"key":"2022031216530761800_R26","doi-asserted-by":"crossref","unstructured":"Sharpey-Schafer EP, Taylor PJ: Absent circulatory reflexes in diabetic neuritis. Lancet\u20081:559\u2013562, 1960","DOI":"10.1016\/S0140-6736(60)92773-2"},{"key":"2022031216530761800_R27","doi-asserted-by":"crossref","unstructured":"Ewing DJ, Irving JB, Kerr F, et al.: Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function. Clin Sci Mol Med\u200846:295\u2013306, 1974","DOI":"10.1042\/cs0460295"},{"key":"2022031216530761800_R28","unstructured":"Morley JE, Asvat MS, Klein C, Lowenthal MN: Autonomic neuropathy in black diabetic patients. S Afr Med J\u200852:115\u2013116, 1977"},{"key":"2022031216530761800_R29","doi-asserted-by":"crossref","unstructured":"Hilsted J, Jensen SB: A simple test for autonomic neuropathy in juvenile diabetics. Acta Med Scand\u2008205:385\u2013387, 1979","DOI":"10.1111\/j.0954-6820.1979.tb06069.x"},{"key":"2022031216530761800_R30","doi-asserted-by":"crossref","unstructured":"Mackay JD, Page MM, Cambridge J, Watkins PJ: Diabetic autonomic neuropathy: the diagnostic value of heart rate monitoring. Diabetologia\u200818:471\u2013478, 1980","DOI":"10.1007\/BF00261703"},{"key":"2022031216530761800_R31","unstructured":"Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med\u200849:95\u2013108, 1980"},{"key":"2022031216530761800_R32","doi-asserted-by":"crossref","unstructured":"Ewing DJ, Campbell IW, Clark BF: Assessment of cardiovascular effects in diabetic autonomic neuropathy and prognostic implications. Ann Intern Med\u200892:308\u2013311, 1980","DOI":"10.7326\/0003-4819-92-2-308"},{"key":"2022031216530761800_R33","unstructured":"Hulper B, Willms B: Investigations of autonomic diabetic neuropathy of the cardiovascular system. Horm Metab Res\u2008Suppl 9:77\u201380, 1980"},{"key":"2022031216530761800_R34","doi-asserted-by":"crossref","unstructured":"Dyrberg T, Benn J, Christiansen JS, Hilsted J, Nerup J: Prevalence of diabetic autonomic neuropathy measured by simple bedside tests. Diabetologia\u200820:190\u2013194, 1981","DOI":"10.1007\/BF00252626"},{"key":"2022031216530761800_R35","unstructured":"Xueli Z, Baidi Z, Guoxian H, Xixing Z, et al.: Peripheral and autonomic nerve function tests in early diagnosis of diabetic neuropathy. Chinese Med J\u200894:495\u2013502, 1981"},{"key":"2022031216530761800_R36","unstructured":"O\u2019Brien IA, McFadden JP, Corrall RJ: The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med\u200879:495\u2013502, 1991"},{"key":"2022031216530761800_R37","doi-asserted-by":"crossref","unstructured":"DCCT Research Group: The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia\u200841:416\u2013423, 1998","DOI":"10.1007\/s001250050924"},{"key":"2022031216530761800_R38","doi-asserted-by":"crossref","unstructured":"Neil HA, Thompson AV, John S, et al.: Diabetic autonomic neuropathy: the prevalence of impaired heart rate variability in a geographically defined population. Diabet Med\u20086:20\u201324, 1989","DOI":"10.1111\/j.1464-5491.1989.tb01133.x"},{"key":"2022031216530761800_R39","unstructured":"O\u2019Brien IA, O\u2019Hare JP, Lewin IG, Corrall RJ: The prevalence of autonomic neuropathy in insulin-dependent diabetes: a controlled study based on heart rate variability. Q J Med\u200861:957\u2013967, 1986"},{"key":"2022031216530761800_R40","doi-asserted-by":"crossref","unstructured":"Verrotti A, Chiarelli F, Blasetti A, Morgese G: Autonomic neuropathy in diabetic children. J Paediatr Child Health\u200831:545\u2013548, 1995","DOI":"10.1111\/j.1440-1754.1995.tb00881.x"},{"key":"2022031216530761800_R41","unstructured":"Ewing DJ: Cardiac autonomic neuropathy. In Diabetes and Heart Disease. Jarret RJ, Ed. Amsterdam, the Netherlands, Elsevier, 1984, p. 99\u2013132"},{"key":"2022031216530761800_R42","doi-asserted-by":"crossref","unstructured":"Maser RE, Lenhard MJ, DeCherney GS: Cardiovascular autonomic neuropathy: the clinical significance of its determination. Endocrinologist\u200810:27\u201333, 2000","DOI":"10.1097\/00019616-200010010-00006"},{"key":"2022031216530761800_R43","unstructured":"Schumer MP, Joyner SA, Pfeifer MA: Cardiovascular autonomic neuropathy testing in patients with diabetes. Diabetes Spectrum\u200811:227\u2013231, 1998"},{"key":"2022031216530761800_R44","doi-asserted-by":"crossref","unstructured":"Ziegler D: Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev\u200810:339\u2013383, 1994","DOI":"10.1002\/dmr.5610100403"},{"key":"2022031216530761800_R45","unstructured":"Vinik AI, Erbas T: Neuropathy. In Handbook of Exercise in Diabetes. Ruderman N, Devlin JT, Schneider SH, Kriska A, Eds. Alexandria, VA, American Diabetes Association, p. 463\u2013496, 2002"},{"key":"2022031216530761800_R46","doi-asserted-by":"crossref","unstructured":"Kahn J, Zola B, Juni J, Vinik AI: Decreased exercise heart rate in diabetic subjects with cardiac autonomic neuropathy. Diabetes Care\u20089:389\u2013394, 1986","DOI":"10.2337\/diacare.9.4.389"},{"key":"2022031216530761800_R47","doi-asserted-by":"crossref","unstructured":"Roy TM, Peterson HR, Snider HL, Cyrus J, et al.: Autonomic influence on cardiovascular performance in diabetic subjects. Am J Med\u200887:382\u2013388, 1989","DOI":"10.1016\/S0002-9343(89)80818-6"},{"key":"2022031216530761800_R48","doi-asserted-by":"crossref","unstructured":"Burgos LG, Ebert TJ, Asiddao C, Turner LA, et al.: Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology\u200870:591\u2013597, 1989","DOI":"10.1097\/00000542-198904000-00006"},{"key":"2022031216530761800_R49","doi-asserted-by":"crossref","unstructured":"Kitamura A, Hoshino T, Kon T, et al.: Patients with diabetic neuropathy are at risk of a greater intraoperative reduction in core temperature. Anesthesiology\u200892:1311\u20131318, 2000","DOI":"10.1097\/00000542-200005000-00019"},{"key":"2022031216530761800_R50","doi-asserted-by":"crossref","unstructured":"Sobotka PA, Liss HP, Vinik AI: Impaired hypoxic ventilatory drive in diabetic patients with autonomic neuropathy. J Clin Endocrinol Metab\u200862:658\u2013663, 1986","DOI":"10.1210\/jcem-62-4-658"},{"key":"2022031216530761800_R51","doi-asserted-by":"crossref","unstructured":"Position paper: Orthostatic hypotension, multiple system atrophy (the Shy Drager syndrome) and pure autonomic failure. J Auton Nerv Syst\u200858:123\u2013124, 1996","DOI":"10.1016\/0165-1838(96)90001-6"},{"key":"2022031216530761800_R52","doi-asserted-by":"crossref","unstructured":"Low PA, Walsh JC, Huang CY, McLeod JG: The sympathetic nervous system in diabetic neuropathy: a clinical and pathological study. Brain\u200898:341\u2013356, 1975","DOI":"10.1093\/brain\/98.3.341"},{"key":"2022031216530761800_R53","doi-asserted-by":"crossref","unstructured":"Hilsted J, Parving HH, Christensen NJ, Benn J, Galbo H: Hemodynamics in diabetic orthostatic hypotension. J Clin Invest\u200868:1427\u20131434, 1981","DOI":"10.1172\/JCI110394"},{"key":"2022031216530761800_R54","doi-asserted-by":"crossref","unstructured":"Hilsted J, Galbo H, Christensen NJ: Impaired cardiovascular responses to graded exercise in diabetic autonomic neuropathy. Diabetes\u200828:313\u2013319, 1979","DOI":"10.2337\/diab.28.4.313"},{"key":"2022031216530761800_R55","doi-asserted-by":"crossref","unstructured":"Cryer PE, Silverberg AB, Santiago JV, Shah SD: Plasma catecholamines in diabetes: the syndromes of hypoadrenergic and hyperadrenergic postural hypotension. Am J Med\u200864:407\u2013416, 1978","DOI":"10.1016\/0002-9343(78)90220-6"},{"key":"2022031216530761800_R56","doi-asserted-by":"crossref","unstructured":"Tohmeh JF, Shah SD, Cryer PE: The pathogenesis of hyperadrenergic postural hypotension in diabetic patients. Am J Med\u200867:772\u2013778, 1979","DOI":"10.1016\/0002-9343(79)90733-2"},{"key":"2022031216530761800_R57","doi-asserted-by":"crossref","unstructured":"Page MM, Watkins PJ: Provocation of postural hypotension by insulin in diabetic autonomic neuropathy. Diabetes\u200825:90\u201395, 1976","DOI":"10.2337\/diabetes.25.2.90"},{"key":"2022031216530761800_R58","doi-asserted-by":"crossref","unstructured":"Mathias CJ, da Costa DF, Fosbraey P, Christensen NJ, Bannister R: Hypotensive and sedative effects of insulin in autonomic failure. Br Med J (Clin Res Ed)\u2008295:161\u2013163, 1987","DOI":"10.1136\/bmj.295.6591.161"},{"key":"2022031216530761800_R59","doi-asserted-by":"crossref","unstructured":"Winocour PH, Dhar H, Anderson DC: The relationship between autonomic neuropathy and urinary sodium and albumin excretion in insulin-treated diabetics. Diabet Med\u20083:436\u2013440, 1986","DOI":"10.1111\/j.1464-5491.1986.tb00786.x"},{"key":"2022031216530761800_R60","unstructured":"Freeman R: Cardiovascular autonomic neuropathy. In Diabetic Neuropathy. 2nd ed. Dyck PJ, Thomas PK, Eds. Philadelphia, WB Saunders, 1999, p. 541\u2013554"},{"key":"2022031216530761800_R61","doi-asserted-by":"crossref","unstructured":"Vinik AI: Diabetic neuropathy: pathogenesis and therapy. Am J Med\u2008107:17S\u201326S, 1999","DOI":"10.1016\/S0002-9343(99)00009-1"},{"key":"2022031216530761800_R62","doi-asserted-by":"crossref","unstructured":"Freeman R: Diabetic autonomic neuropathy: an overview. In Clinical Management of Diabetic Neuropathy. Veves A, Ed. Totowa, NJ, Humana Press, 1998, p. 181\u2013208","DOI":"10.1007\/978-1-4612-1816-6_12"},{"key":"2022031216530761800_R63","doi-asserted-by":"crossref","unstructured":"Niakan E, Harati Y, Rolak LA, Comstock JP, Rokey R: Silent myocardial infarction and diabetic cardiovascular autonomic neuropathy. Arch Intern Med\u2008146:2229\u20132230, 1986","DOI":"10.1001\/archinte.146.11.2229"},{"key":"2022031216530761800_R64","doi-asserted-by":"crossref","unstructured":"Hume L, Oakley GD, Boulton AJ, Hardisty C, Ward JD: Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: an exercise electrocardiography study in middle-aged diabetic men. Diabetes Care\u20089:384\u2013388, 1986","DOI":"10.2337\/diacare.9.4.384"},{"key":"2022031216530761800_R65","doi-asserted-by":"crossref","unstructured":"Murray DP, O\u2019Brien T, Mulrooney R, O\u2019Sullivan DJ: Autonomic dysfunction and silent myocardial ischaemia on exercise testing in diabetes mellitus. Diabet Med\u20087:580\u2013584, 1990","DOI":"10.1111\/j.1464-5491.1990.tb01452.x"},{"key":"2022031216530761800_R66","doi-asserted-by":"crossref","unstructured":"Langer A, Freeman MR, Josse RG, Steiner G, Armstrong PW: Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol\u200867:1073\u20131078, 1991","DOI":"10.1016\/0002-9149(91)90868-L"},{"key":"2022031216530761800_R67","doi-asserted-by":"crossref","unstructured":"O\u2019Sullivan JJ, Conroy RM, MacDonald K, McKenna TJ, Mauerer BJ: Silent ischemia in diabetic men with autonomic neuropathy. Br Heart J\u200866:313\u2013315, 1991","DOI":"10.1136\/hrt.66.4.313"},{"key":"2022031216530761800_R68","doi-asserted-by":"crossref","unstructured":"Koistinen MJ, Airaksinen KE, Huikuri HV, Pirttiaho H, Linnaluoto MK, Ikaheimo MJ, Takkunen JT: Asymptomatic coronary artery disease in diabetes: associated with autonomic neuropathy? Acta Diabetol\u200828:199\u2013202, 1992","DOI":"10.1007\/BF00778998"},{"key":"2022031216530761800_R69","doi-asserted-by":"crossref","unstructured":"Hartmann A, Schlottog B, Jungmann E, Bohm BO, Usadel KH, Kaltenbach M: Somatic pain threshold and reactive hyperemia in autonomic diabetic neuropathy and silent myocardial ischemia. Int J Cardiol\u200842:121\u2013127, 1993","DOI":"10.1016\/0167-5273(93)90081-Q"},{"key":"2022031216530761800_R70","doi-asserted-by":"crossref","unstructured":"Jermendy G, Davidovits Z, Khoor S: Silent coronary artery disease in diabetic patients with cardiac autonomic neuropathy. Diabetes Care\u200817:1231\u20131232, 1994","DOI":"10.2337\/diacare.17.10.1231"},{"key":"2022031216530761800_R71","doi-asserted-by":"crossref","unstructured":"Zarich S, Waxman S, Freeman RT, Mittleman M, Hegarty P, Nesto RW: Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus. J Am Coll Cardiol\u200824:956\u2013962, 1994","DOI":"10.1016\/0735-1097(94)90855-9"},{"key":"2022031216530761800_R72","doi-asserted-by":"crossref","unstructured":"Milan Study on Atherosclerosis and Diabetes (MiSAD) Group: Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol\u200879:134\u2013139, 1997","DOI":"10.1016\/S0002-9149(96)00699-6"},{"key":"2022031216530761800_R73","unstructured":"Jalal S, Alai MS, Khan KA, Jan VM, Rather HA, Iqbal K, Tramboo NA, Lone NA, Dar MA, Hayat A, Abbas SM: Silent myocardial ischemia and cardiac autonomic neuropathy in diabetics. J Assoc Physicians India\u200847:767\u2013769, 1999"},{"key":"2022031216530761800_R74","doi-asserted-by":"crossref","unstructured":"Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR: Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care\u200824:339\u2013343, 2001","DOI":"10.2337\/diacare.24.2.339"},{"key":"2022031216530761800_R75","doi-asserted-by":"crossref","unstructured":"Ambepityia G, Kopelman PG, Ingram D, Swash M, Mills PG, Timmis AD: Exertional myocardial ischemia in diabetes: a quantitative analysis of anginal perceptual threshold and the influence of autonomic function. J Am Coll Cardiol\u200815:72\u201377, 1990","DOI":"10.1016\/0735-1097(90)90178-R"},{"key":"2022031216530761800_R76","doi-asserted-by":"crossref","unstructured":"Marchant B, Umachandran V, Stevenson R, Kopelman PG, Timmis AD: Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol\u200822:1433\u20131437, 1993","DOI":"10.1016\/0735-1097(93)90554-E"},{"key":"2022031216530761800_R77","doi-asserted-by":"crossref","unstructured":"Hikita H, Kurita A, Takase B, Nagayoshi H, Uehata A, Nishioka T, Mitani H, Mizuno K, Nakamura H: Usefulness of plasma beta-endorphin level, pain threshold and autonomic function in assessing silent myocardial ischemia in patients with and without diabetes mellitus. Am J Cardiol\u200872:140\u2013143, 1993","DOI":"10.1016\/0002-9149(93)90149-7"},{"key":"2022031216530761800_R78","doi-asserted-by":"crossref","unstructured":"Langer A, Freeman MR, Josse RG, Armstrong PW: Metaiodobenzylguanidine imaging in diabetes mellitus: assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia. J Am Coll Cardiol\u200825:610\u2013618, 1995","DOI":"10.1016\/0735-1097(94)00459-4"},{"key":"2022031216530761800_R79","doi-asserted-by":"crossref","unstructured":"Airaksinen KEJ, Koistinen MJ: Association between silent coronary artery disease, diabetes, and autonomic neuropathy. Diabetes Care\u200815:288\u2013292, 1992","DOI":"10.2337\/diacare.15.2.288"},{"key":"2022031216530761800_R80","doi-asserted-by":"crossref","unstructured":"Airaksinen KE, Ikaheimo MJ, Linnaluoto MK, Niemela M, Takkunen JT: Impaired vagal heart rate control in coronary artery disease. Br Heart J\u200858:592\u2013597, 1987","DOI":"10.1136\/hrt.58.6.592"},{"key":"2022031216530761800_R81","doi-asserted-by":"crossref","unstructured":"Campbell IW, Ewing DJ, Clarke BF: Painful myocardial infarction in severe diabetic autonomic neuropathy. Acta Diabetol Lat\u200815:210\u2013214, 1978","DOI":"10.1007\/BF02581065"},{"key":"2022031216530761800_R82","unstructured":"Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ: Progression of diabetic autonomic neuropathy over a decade of insulin-dependent diabetics. Q J Med\u200875:635\u2013646, 1990"},{"key":"2022031216530761800_R83","doi-asserted-by":"crossref","unstructured":"Ewing DJ, Boland O, Neilson JM, Cho CG, Clarke BF: Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients. Diabetologia\u200834:182\u2013185, 1991","DOI":"10.1007\/BF00418273"},{"key":"2022031216530761800_R84","unstructured":"Jermendy G, Toth L, Voros P, Koltai MZ, Pogatsa G: Cardiac autonomic neuropathy and QT interval length: a follow-up study in diabetic patients. Acta Cardiol\u200846:189\u2013200, 1991"},{"key":"2022031216530761800_R85","doi-asserted-by":"crossref","unstructured":"Rathmann W, Ziegler D, Jahnke M, et al.: Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med\u200810:820\u2013824, 1993","DOI":"10.1111\/j.1464-5491.1993.tb00173.x"},{"key":"2022031216530761800_R86","doi-asserted-by":"crossref","unstructured":"Hathaway DK, El-Gebely S, Cardoso SS, Elmer DS, Gaber AO: Autonomic control dysfunction in diabetic transplant recipients succumbing to sudden cardiac death. Transplantation\u200859:634\u2013637, 1995","DOI":"10.1097\/00007890-199559040-00034"},{"key":"2022031216530761800_R87","doi-asserted-by":"crossref","unstructured":"Orchard TJ, Lloyd CE, Maser RE, Kuller LH: Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Res Clin Pract\u200834 (Suppl.):S165\u2013S171, 1996","DOI":"10.1016\/S0168-8227(96)90025-X"},{"key":"2022031216530761800_R88","doi-asserted-by":"crossref","unstructured":"Sawicki PT, Bender DR, Berger M: Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia\u200839:77\u201381, 1996","DOI":"10.1007\/BF00400416"},{"key":"2022031216530761800_R89","doi-asserted-by":"crossref","unstructured":"Navarro X, Kennedy WR, Aeppli D, Sutherland DE: Neuropathy and mortality in diabetes: influence of pancreas transplantation. Muscle Nerve\u200819:1009\u20131016, 1996","DOI":"10.1002\/(SICI)1097-4598(199608)19:8<1009::AID-MUS9>3.0.CO;2-4"},{"key":"2022031216530761800_R90","doi-asserted-by":"crossref","unstructured":"Toyry JP, Niskanen LK, Mantysaari MJ, Lansimies EA, Uusitupa MIJ: Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM: ten-year follow-up from the diagnosis. Diabetes\u200845:308\u2013315, 1996","DOI":"10.2337\/diabetes.45.3.308"},{"key":"2022031216530761800_R91","doi-asserted-by":"crossref","unstructured":"Sawicki PT, Kiwitt S, Bender R, Berger M: The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med\u2008243:49\u201356, 1998","DOI":"10.1046\/j.1365-2796.1998.00259.x"},{"key":"2022031216530761800_R92","doi-asserted-by":"crossref","unstructured":"Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P: QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study: Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care\u200823:1381\u20131383, 2000","DOI":"10.2337\/diacare.23.9.1381"},{"key":"2022031216530761800_R93","doi-asserted-by":"crossref","unstructured":"Gerritsen J, Dekker JM, ten Voorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD: Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care\u200824:1793\u20131798, 2001","DOI":"10.2337\/diacare.24.10.1793"},{"key":"2022031216530761800_R94","doi-asserted-by":"crossref","unstructured":"Chen HS, Hwu CM, Kuo BI, Chiang SC, Kwok CF, Lee SH, Lee YS, Weih MJ, Hsiao LC, Lin SH, Ho LT: Abnormal cardiovascular reflex tests are predictors of mortality in type 2 diabetes mellitus. Diabet Med\u200818:268\u2013273, 2001","DOI":"10.1046\/j.1464-5491.2001.00442.x"},{"key":"2022031216530761800_R94A","unstructured":"Maser RE, Mitchell BD, Vinik AI, Freeman R: The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes. Diabetes Care. In press"},{"key":"2022031216530761800_R95","doi-asserted-by":"crossref","unstructured":"Ewing DJ, Martyn CN, Young RJ, Clarke BF: The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care\u20088:491\u2013498, 1985","DOI":"10.2337\/diacare.8.5.491"},{"key":"2022031216530761800_R96","doi-asserted-by":"crossref","unstructured":"Page MM, Watkins PJ: Cardiorespiratory arrest and diabetic autonomic neuropathy. Lancet\u20081:14\u201316, 1978","DOI":"10.1016\/S0140-6736(78)90360-4"},{"key":"2022031216530761800_R97","doi-asserted-by":"crossref","unstructured":"Maser RE, Pfeifer MA, Dorman JS, Kuller LH, Becker DJ, Orchard TJ: Diabetic autonomic neuropathy and cardiovascular risk: Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med\u2008150:1218\u20131222, 1990","DOI":"10.1001\/archinte.150.6.1218"},{"key":"2022031216530761800_R98","doi-asserted-by":"crossref","unstructured":"Spallone V, Maiello MR, Cicconetti E, Menzinger G: Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. Diabetes Res Clin Pract\u200834(Suppl. 3):169\u2013179, 1997","DOI":"10.1016\/S0168-8227(96)01354-X"},{"key":"2022031216530761800_R99","doi-asserted-by":"crossref","unstructured":"Cohen JA, Jeffers BW, Faldut D, Marcoux M, Schrier RW: Risks for sensorimotor peripheral neuropathy and autonomic neuropathy in non-insulin-dependent diabetes mellitus (NIDDM). Muscle Nerve\u200821:72\u201380, 1998","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<72::AID-MUS10>3.0.CO;2-2"},{"key":"2022031216530761800_R100","doi-asserted-by":"crossref","unstructured":"Menzinger G, Gambardella S, Spallone V: The relationship of autonomic neuropathy to other diabetic complications. Diabet Med\u200810(Suppl. 2):74S\u201376S, 1993","DOI":"10.1111\/j.1464-5491.1993.tb00205.x"},{"key":"2022031216530761800_R101","doi-asserted-by":"crossref","unstructured":"Sivieri R, Veglio M, Chinaglia A, et al.: Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. Diabet Med\u200810:920\u2013924, 1993","DOI":"10.1111\/j.1464-5491.1993.tb00007.x"},{"key":"2022031216530761800_R102","doi-asserted-by":"crossref","unstructured":"Veglio M, Borra M, Stevens LK, Fuller JH, et al.: The relation between QTc interval prolongation and diabetic complications: the EURODIAB IDDM Complications Study Group. Diabetologia\u200842:68\u201375, 1999","DOI":"10.1007\/s001250051115"},{"key":"2022031216530761800_R103","unstructured":"Kahn JK, Sisson JC, Vinik AI: Prediction of sudden cardiac death in diabetic autonomic neuropathy. J Nucl Med\u200829:1605\u20131606, 1988"},{"key":"2022031216530761800_R104","doi-asserted-by":"crossref","unstructured":"Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, Wieland DM, Pfeifer MA, Schwaiger M: Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation\u200898:961\u2013968, 1998","DOI":"10.1161\/01.CIR.98.10.961"},{"key":"2022031216530761800_R105","unstructured":"Suarez GA, Kottke TE, Callahan MJ, Norell JE, O\u2019Brien PC, Dyck PJ: Is autonomic neuropathy an important cause of sudden death in diabetes mellitus? (Abstract) Neurology\u200856(Suppl. 3):A208, 2001"},{"key":"2022031216530761800_R106","unstructured":"Johnson BF, Nesto R, Pfeifer M, Slater W, Vinik A, Wackers F, Young L: Systolic and diastolic dysfunction in diabetic patients with neuropathy (Abstract). Diabetes\u200846(Suppl. 1):314A, 1997"},{"key":"2022031216530761800_R107","doi-asserted-by":"crossref","unstructured":"Miettinen H, Lehto S, Salomaa V, Mahonen M, Niemela M, Haffner SM, Pyorala K, Tuomilehto J: Impact of diabetes on mortality after the first myocardial infarction: The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care\u200821:69\u201375, 1998","DOI":"10.2337\/diacare.21.1.69"},{"key":"2022031216530761800_R108","doi-asserted-by":"crossref","unstructured":"Fava S, Azzopardi J, Muscat HA, Fennech FF: Factors that influence outcome in diabetic subjects with myocardial infarction. Diabetes Care\u200816:1615\u20131618, 1993","DOI":"10.2337\/diacare.16.12.1615"},{"key":"2022031216530761800_R109","doi-asserted-by":"crossref","unstructured":"Katz A, Liberty IF, Porath A, Ovsyshcher I, Prystowsky EN: A simple beside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction. Am Heart J\u2008138:32\u201338, 1999","DOI":"10.1016\/S0002-8703(99)70242-5"},{"key":"2022031216530761800_R110","doi-asserted-by":"crossref","unstructured":"Toyry JP, Niskanen LK, Lansimies EA, Partanen KPL, Uusitupa MIJ: Autonomic neuropathy predicts the development of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke\u200827:1316\u20131318, 1996","DOI":"10.1161\/01.STR.27.8.1316"},{"key":"2022031216530761800_R111","doi-asserted-by":"crossref","unstructured":"Ewing DJ: Diabetic autonomic neuropathy and the heart. Diabetes Res Clin Pract\u200830 (Suppl.)S31\u2013S36, 1996","DOI":"10.1016\/S0168-8227(96)80036-2"},{"key":"2022031216530761800_R112","doi-asserted-by":"crossref","unstructured":"Fraser DM, Campbell IW, Ewing DJ, Murray A, Neilson JM, Clarke BF: Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes\u200826:546\u2013550, 1977","DOI":"10.2337\/diabetes.26.6.546"},{"key":"2022031216530761800_R113","doi-asserted-by":"crossref","unstructured":"Vinik AI, Milicevic Z: Recent advances in the diagnosis and treatment of diabetic neuropathy. Endocrinologist\u20086:443\u2013461, 1996","DOI":"10.1097\/00019616-199611000-00005"},{"key":"2022031216530761800_R114","doi-asserted-by":"crossref","unstructured":"Javorka K, Javorkova J, Petraskova M, et al.: Heart rate variability and cardiovascular tests in young patients with diabetes mellitus type 1. J Pediatr Endocrinol Metab\u200812:423\u2013431, 1999","DOI":"10.1515\/JPEM.1999.12.3.423"},{"key":"2022031216530761800_R115","doi-asserted-by":"crossref","unstructured":"Young RJ, Ewing DJ, Clarke BF: Nerve function and metabolic control in teenage diabetics. Diabetes\u200832:142\u2013147, 1983","DOI":"10.2337\/diabetes.32.2.142"},{"key":"2022031216530761800_R116","unstructured":"Ewing DJ, Clarke BF: Diabetic autonomic neuropathy: a clinical viewpoint. In Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Weingrad AI, Porte D, Eds. Philadelphia, WB Saunders, 1987, p. 66\u201388"},{"key":"2022031216530761800_R117","doi-asserted-by":"crossref","unstructured":"Karavanaki K, Baum JD: Prevalence of microvascular and neurologic abnormalities in a population of diabetic children. J Pediatr Endocrinol\u200812:411\u2013422, 1999","DOI":"10.1515\/JPEM.1999.12.3.411"},{"key":"2022031216530761800_R118","unstructured":"Low PA, Fealey RD: Sudomotor neuropathy: In Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Weingrad AI, Porte D, Eds. Philadelphia, WB Saunders, 1987, p. 140\u2013145"},{"key":"2022031216530761800_R119","unstructured":"DePonti F, Fealey RD, Malagelada JR: Gastrointestinal syndromes due to diabetes mellitus. In Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Weingrad AI, Porte D, Eds. Philadelphia, WB Saunders, 1987, p. 155\u2013161"},{"key":"2022031216530761800_R120","unstructured":"Smith SA, Smith SE: Assessment of pupillary function in diabetic neuropathy. In Diabetic Neuropathy. Dyck PJ, Thomas PK, Asbury AK, Weingrad AI, Porte D, Eds. Philadelphia, WB Saunders, 1987, p. 134\u2013139"},{"key":"2022031216530761800_R121","doi-asserted-by":"crossref","unstructured":"Levitt NS, Stansberry KB, Wynchank S, Vinik AI: The natural progression of autonomic neuropathy and autonomic function tests in a cohort of people with IDDM. Diabetes Care\u200819:751\u2013754, 1996","DOI":"10.2337\/diacare.19.7.751"},{"key":"2022031216530761800_R122","doi-asserted-by":"crossref","unstructured":"Farup CE, Leidy NK, Murray M, Williams GR, Helbers L, Quigley EMM: Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care\u200821:1699\u20131706, 1998","DOI":"10.2337\/diacare.21.10.1699"},{"key":"2022031216530761800_R123","doi-asserted-by":"crossref","unstructured":"Channer KS, Jackson PC, O\u2019Brien I, Corrall RJ, Coles DR, Davies ER, Virjee JP: Oesophageal function in diabetes mellitus and its association with autonomic neuropathy. Diabet Med\u20082:378\u2013382, 1985","DOI":"10.1111\/j.1464-5491.1985.tb00656.x"},{"key":"2022031216530761800_R124","doi-asserted-by":"crossref","unstructured":"Kong MF, Horowitz M, Jones KL, Wishart JM, Harding PE: Natural history of diabetic gastroparesis. Diabetes Care\u200822:503\u2013507, 1999","DOI":"10.2337\/diacare.22.3.503"},{"key":"2022031216530761800_R125","doi-asserted-by":"crossref","unstructured":"Horowitz M, Edelbroek M, Fraser R, Maddox A, Wishart J: Disordered gastric motor function in diabetes mellitus: recent insights into prevalence, pathophysiology, clinical relevance and treatment. Scand J Gastroenterol\u200826:673\u2013684, 1991","DOI":"10.3109\/00365529108998583"},{"key":"2022031216530761800_R126","doi-asserted-by":"crossref","unstructured":"Schiller LR, Santa Ana CA, Schmulen AC, Hendler RS, Harford WV, Fordtran JS: Pathogenesis of fecal incontinence in diabetes mellitus: evidence for internal-anal-sphincter dysfunction. N Engl J Med\u2008307:1666\u20131671, 1982","DOI":"10.1056\/NEJM198212303072702"},{"key":"2022031216530761800_R127","unstructured":"Neumann C, Schmid H: Relationship between the degree of cardiovascular autonomic dysfunction and symptoms of neuropathy and other complications of diabetes mellitus. Braz J Med Biol Res\u200828:751\u2013757, 1995"},{"key":"2022031216530761800_R128","doi-asserted-by":"crossref","unstructured":"Blaivas JG: The neurophysiology of micturition: a clinical study of 550 patients. J Urol\u2008127:958\u2013963, 1982","DOI":"10.1016\/S0022-5347(17)54147-6"},{"key":"2022031216530761800_R129","doi-asserted-by":"crossref","unstructured":"Ellenberg M: Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med\u200892:321\u2013323, 1980","DOI":"10.7326\/0003-4819-92-2-321"},{"key":"2022031216530761800_R130","doi-asserted-by":"crossref","unstructured":"Bradley WE: Diagnosis of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med\u200892:323\u2013326, 1980","DOI":"10.7326\/0003-4819-92-2-323"},{"key":"2022031216530761800_R131","doi-asserted-by":"crossref","unstructured":"Beylot M, Marion D, Noel G: Ultrasonographic determination of residual urine in diabetic subjects: relationship to neuropathy and urinary tract infection. Diabetes Care\u20085:501\u2013505, 1982","DOI":"10.2337\/diacare.5.5.501"},{"key":"2022031216530761800_R132","doi-asserted-by":"crossref","unstructured":"Norden G, Granerus G, Nyberg G: Diabetic cystopathy: a risk factor in diabetic nephropathy? J Diabet Complications\u20082:203\u2013206, 1988","DOI":"10.1016\/S0891-6632(88)80009-6"},{"key":"2022031216530761800_R133","doi-asserted-by":"crossref","unstructured":"Frimodt-Moller C, Mortensen S: Treatment of diabetic cystopathy. Ann Intern Med\u200892:327\u2013328, 1980","DOI":"10.7326\/0003-4819-92-2-327"},{"key":"2022031216530761800_R134","doi-asserted-by":"crossref","unstructured":"Ioanid CP, Noica N: Incidence and diagnostic aspects of the bladder disorders in diabetics. Eur Urol\u20087:211\u2013214, 1981","DOI":"10.1159\/000473221"},{"key":"2022031216530761800_R135","doi-asserted-by":"crossref","unstructured":"McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF: The prevalence of diabetic impotence. Diabetologia\u200818:279\u2013283, 1980","DOI":"10.1007\/BF00251005"},{"key":"2022031216530761800_R136","doi-asserted-by":"crossref","unstructured":"Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol\u2008151:54\u201361, 1994","DOI":"10.1016\/S0022-5347(17)34871-1"},{"key":"2022031216530761800_R137","doi-asserted-by":"crossref","unstructured":"Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB: Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care\u200825:1458\u20131463, 2002","DOI":"10.2337\/diacare.25.8.1458"},{"key":"2022031216530761800_R138","unstructured":"Vinik AI, Richardson D: Erectile dysfunction in diabetes. Diabetes Reviews\u20086:16\u201333, 1998"},{"key":"2022031216530761800_R139","doi-asserted-by":"crossref","unstructured":"Enzlin P, Mathieu C, Vanderschueren D, Demyttenaere K: Diabetes mellitus and female sexuality: a review of 25 years\u2019 research. Diabet Med\u200815:809\u2013815, 1998","DOI":"10.1002\/(SICI)1096-9136(199810)15:10<809::AID-DIA689>3.0.CO;2-Z"},{"key":"2022031216530761800_R140","doi-asserted-by":"crossref","unstructured":"Bosman DR, Osborne CA, Marsden JT, Macdougall IC, Gardner WN, Watkins PJ: Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure. Diabet Med\u200819:65\u201369, 2002","DOI":"10.1046\/j.1464-5491.2002.00634.x"},{"key":"2022031216530761800_R141","doi-asserted-by":"crossref","unstructured":"Robertson D, Krantz SB, Biaggioni I, Robertson D: The anemia of microgravity and recumbency: role of sympathetic neural control of erythropoietin production. Acta Astronautica\u200833:137\u2013141, 1994","DOI":"10.1016\/0094-5765(94)90118-X"},{"key":"2022031216530761800_R142","doi-asserted-by":"crossref","unstructured":"Ryder RE, Owens DR, Hayes TM, Ghatei MA, Bloom SR: Unawareness of hypoglycaemia and inadequate hypoglycaemic counterregulation: no causal relation with diabetic autonomic neuropathy. Br Med J\u2008301:783\u2013787, 1990","DOI":"10.1136\/bmj.301.6755.783"},{"key":"2022031216530761800_R143","doi-asserted-by":"crossref","unstructured":"Hepburn DA, Patrick AW, Eadington DW, Ewing DJ, Frier BM: Unawareness of hypoglycaemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy. Diabet Med\u20087:711\u2013717, 1990","DOI":"10.1111\/j.1464-5491.1990.tb01475.x"},{"key":"2022031216530761800_R144","doi-asserted-by":"crossref","unstructured":"Bottini P, Boschetti E, Pampanelli S, Ciofetta M, Del Sindaco P, Scionti L, Brunetti P, Bolli GB: Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. Diabetes\u200846:814\u2013823, 1997","DOI":"10.2337\/diabetes.46.5.814"},{"key":"2022031216530761800_R145","doi-asserted-by":"crossref","unstructured":"Fanelli C, Pampanelli S, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Porcellati F, Bottini P, Di Vincenzo A, Brunetti P, Bolli GB: Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. Diabetes\u200846:1172\u20131181, 1997","DOI":"10.2337\/diabetes.46.7.1172"},{"key":"2022031216530761800_R146","doi-asserted-by":"crossref","unstructured":"Meyer C, Grossmann R, Mitrakou A, Mahler R, Veneman T, Gerich J, Bretzel RG: Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients. Diabetes Care\u200821:1960\u20131966, 1998","DOI":"10.2337\/diacare.21.11.1960"},{"key":"2022031216530761800_R147","doi-asserted-by":"crossref","unstructured":"Cryer PE: Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes\u200841:255\u2013260, 1992","DOI":"10.2337\/diab.41.3.255"},{"key":"2022031216530761800_R148","doi-asserted-by":"crossref","unstructured":"Dagogo-Jack SE, Craft S, Cryer PE: Hypoglycemia-associated autonomicfailure in insulin-dependent diabetes mellitus: recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia. J Clin Invest\u200891:819\u2013828, 1993","DOI":"10.1172\/JCI116302"},{"key":"2022031216530761800_R149","doi-asserted-by":"crossref","unstructured":"Cryer PE: Hypoglycemia-associated autonomic failure in diabetes. Am J Physiol Endocrinol Metab\u2008281:E1115\u2013E1121, 2001","DOI":"10.1152\/ajpendo.2001.281.6.E1115"},{"key":"2022031216530761800_R150","doi-asserted-by":"crossref","unstructured":"Hoeldtke RD, Boden G: Epinephrine secretion, hypoglycemia unawareness, and diabetic autonomic neuropathy. Ann Intern Med\u2008120:512\u2013517, 1994","DOI":"10.7326\/0003-4819-120-6-199403150-00011"},{"key":"2022031216530761800_R151","doi-asserted-by":"crossref","unstructured":"Stephenson JM, Kempler P, Perin PC, Fuller JH: Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications Study. Diabetologia\u200839:1372\u20131376, 1996","DOI":"10.1007\/s001250050585"},{"key":"2022031216530761800_R152","doi-asserted-by":"crossref","unstructured":"Low P, Lagerlund TD, McManis PG: Nerve blood flow and oxygen delivery in normal, diabetic, and ischemic neuropathy. Int Rev Neurobiol\u200831:355\u2013438, 1989","DOI":"10.1016\/S0074-7742(08)60283-4"},{"key":"2022031216530761800_R153","doi-asserted-by":"crossref","unstructured":"Stansberry KB, Hill MA, Shapiro SA, McNitt PM, Bhatt BA, Vinik AI: Impairment of peripheral blood flow responses in diabetes resembles an enhanced aging effect. Diabetes Care\u200820:1711\u20131716, 1997","DOI":"10.2337\/diacare.20.11.1711"},{"key":"2022031216530761800_R154","doi-asserted-by":"crossref","unstructured":"Stansberry KB, Peppard HR, Babyak LM, Popp G, McNitt PM, Vinik AI: Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care\u200822:1549\u20131554, 1999","DOI":"10.2337\/diacare.22.9.1549"},{"key":"2022031216530761800_R155","doi-asserted-by":"crossref","unstructured":"Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG: A prospective study of risk factors for diabetic foot ulcer: the Seattle Diabetic Foot Study. Diabetes Care\u200822:1036\u20131042, 1999","DOI":"10.2337\/diacare.22.7.1036"},{"key":"2022031216530761800_R156","doi-asserted-by":"crossref","unstructured":"Young MJ, Marshall A, Adams JE, Selby PL, Boulton AJM: Osteopenia, neurological dysfunction, and the development of charcot neuroarthropathy. Diabetes Care\u200818:34\u201338, 1995","DOI":"10.2337\/diacare.18.1.34"},{"key":"2022031216530761800_R157","unstructured":"American Diabetes Association and American Academy of Neurology: Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diabetes Care\u200815:1080\u20131107, 1992"},{"key":"2022031216530761800_R158","doi-asserted-by":"crossref","unstructured":"Pfeifer MA, Cook D, Brodsky J, Tice D, Reenan A, Swedine S, Halter JB, Porte D Jr: Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes\u200831:339\u2013345, 1982","DOI":"10.2337\/diabetes.31.4.339"},{"key":"2022031216530761800_R159","doi-asserted-by":"crossref","unstructured":"Ewing DJ, Campbell IW, Murray H, Neilson JM, Clarke BF: Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. BMJ\u20081:145\u2013147, 1978","DOI":"10.1136\/bmj.1.6106.145"},{"key":"2022031216530761800_R160","doi-asserted-by":"crossref","unstructured":"Borst C, Weiling W, van Brederode JFM, Hond A, DeRijk LG, Dunning AJ: Mechanisms of initial heart rate response to postural change. Am J Physiol\u2008243:H676\u2013H681, 1982","DOI":"10.1152\/ajpheart.1982.243.5.H676"},{"key":"2022031216530761800_R161","doi-asserted-by":"crossref","unstructured":"Ziegler D, Laux G, Dannehl K, Spuler M, et al.: Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med\u20089:166\u2013175, 1992","DOI":"10.1111\/j.1464-5491.1992.tb01754.x"},{"key":"2022031216530761800_R162","doi-asserted-by":"crossref","unstructured":"Sandroni P, Benarroch EE, Low PA: Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure. J Appl Physiol\u200871:1563\u20131567, 1991","DOI":"10.1152\/jappl.1991.71.4.1563"},{"key":"2022031216530761800_R163","unstructured":"American Academy of Neurology Therapeutics and Technology Assessment Subcommittee: Assessment: clinical autonomic testing report. Neurology\u200846:873\u2013880, 1996"},{"key":"2022031216530761800_R164","doi-asserted-by":"crossref","unstructured":"Pfeifer MA, Schumer MP, Gelber DA: Aldose reductase inhibitors: the end of an era or the need for different trial designs? Diabetes\u200846(Suppl. 2):S82\u2013S89, 1997","DOI":"10.2337\/diab.46.2.S82"},{"key":"2022031216530761800_R165","unstructured":"Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation\u200893:1043\u20131065, 1996"},{"key":"2022031216530761800_R166","doi-asserted-by":"crossref","unstructured":"Freeman R, Saul P, Roberts M, Berger RD, Broadbridge C, Cohen R: Spectral analysis of heart rate in diabetic autonomic neuropathy. Arch Neurol\u200848:185\u2013190, 1991","DOI":"10.1001\/archneur.1991.00530140079020"},{"key":"2022031216530761800_R167","doi-asserted-by":"crossref","unstructured":"Howorka K, Pumprla J, Schabmann A: Optimal parameters for short-term heart rate spectrogram for routine evaluation of diabetic cardiovascular autonomic neuropathy. J Auton Nerv Syst\u200869:164\u2013172, 1998","DOI":"10.1016\/S0165-1838(98)00015-0"},{"key":"2022031216530761800_R168","unstructured":"Vinik AI, Suwanwalaikorn S: Autonomic neuropathy. In Current Therapy of Diabetes Mellitus. De Fronzo RM, Ed. St. Louis, MO, Yearbook, 1997, p. 165\u2013176"},{"key":"2022031216530761800_R169","doi-asserted-by":"crossref","unstructured":"Vinik AI, Holland MT, Le Beau JM, Liuzzi FJ, Stansberry KB, Colen LB: Diabetic neuropathies. Diabetes Care\u200815:1926\u20131975, 1992","DOI":"10.2337\/diacare.15.12.1926"},{"key":"2022031216530761800_R170","doi-asserted-by":"crossref","unstructured":"Battle WM, Snape WJ Jr, Alavi A, Cohen S, Braunstein S: Colonic dysfunction in diabetes mellitus. Gastroenterology\u200879:1217\u20131221, 1980","DOI":"10.1016\/0016-5085(80)90916-6"},{"key":"2022031216530761800_R171","doi-asserted-by":"crossref","unstructured":"Sundkvist G: Autonomic nervous function in asymptomatic diabetic patients with signs of peripheral neuropathy. Diabetes Care\u20084:529\u2013534, 1981","DOI":"10.2337\/diacare.4.5.529"},{"key":"2022031216530761800_R172","doi-asserted-by":"crossref","unstructured":"Weinberg CR, Pfeifer MA: Development of a predictive model for symptomatic neuropathy in diabetes. Diabetes\u200835:873\u2013880, 1986","DOI":"10.2337\/diabetes.35.8.873"},{"key":"2022031216530761800_R173","doi-asserted-by":"crossref","unstructured":"Mustonen J, Uusitipa M, Mantysaari M, et al.: Changes in autonomic nervous function during the 4-year follow-up in middle-aged diabetic and nondiabetic subjects initially free of coronary heart disease. J Intern Med\u2008241:227\u2013235, 1997","DOI":"10.1046\/j.1365-2796.1997.116126000.x"},{"key":"2022031216530761800_R174","doi-asserted-by":"crossref","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, Hamman RE, Lachin JM, Walker EA, Nathan DM: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med\u2008346:393\u2013403, 2002","DOI":"10.1056\/NEJMoa012512"},{"key":"2022031216530761800_R175","doi-asserted-by":"crossref","unstructured":"Wein TH, Albers JW: Diabetic neuropathies. Phys Med Rehabil Clin N Am\u200812:307\u2013320, 2001","DOI":"10.1016\/S1047-9651(18)30071-8"},{"key":"2022031216530761800_R176","unstructured":"Karavanaki-Karanassiou K: Autonomic neuropathy in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab\u200814(Suppl. 5):1379\u20131386, 2001"},{"key":"2022031216530761800_R177","doi-asserted-by":"crossref","unstructured":"Massin MM, Derkenne B, Tallsund M, Rocour-Brumioul D, Ernould C, Lebrethon MC, Bourguignon JP: Cardiac autonomic dysfunction in diabetic children. Diabetes Care\u200822:1845\u20131850, 1999","DOI":"10.2337\/diacare.22.11.1845"},{"key":"2022031216530761800_R178","doi-asserted-by":"crossref","unstructured":"DCCT Research Group: Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes\u200837:476\u2013481, 1988","DOI":"10.2337\/diabetes.37.4.476"},{"key":"2022031216530761800_R179","doi-asserted-by":"crossref","unstructured":"Jaffe RS, Aoki TT, Rohatsch PL, Disbrow EA, Fung DL: Predicting cardiac autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus. Clin Auton Res\u20085:155\u2013158, 1995","DOI":"10.1007\/BF01826198"},{"key":"2022031216530761800_R180","doi-asserted-by":"crossref","unstructured":"May O, Arildsen H, Damsgaard EM, Mickley H: Cardiovascular autonomic neuropathy in insulin-dependent diabetes mellitus: prevalence and estimated risk of coronary heart disease in the general population. J Intern Med\u2008248:483\u2013491, 2000","DOI":"10.1046\/j.1365-2796.2000.00756.x"},{"key":"2022031216530761800_R181","unstructured":"Clark CM, Vinicor F: Introduction: Risks and benefits of intensive management in non-insulin-dependent diabetes mellitus: the fifth Regenstrief conference. Ann Intern Med\u2008124:81\u201385, 1996"},{"key":"2022031216530761800_R182","doi-asserted-by":"crossref","unstructured":"Pfeifer MA, Schumer MP: Clinical trials of diabetic neuropathy: past, present, and future. Diabetes\u200844:1355\u20131361, 1995","DOI":"10.2337\/diabetes.44.12.1355"},{"key":"2022031216530761800_R183","unstructured":"Feldman EL, Stevens MJ, Greene DA: Pathogenesis of diabetic neuropathy. Clin Neurosci\u20084:365\u2013370, 1997"},{"key":"2022031216530761800_R184","doi-asserted-by":"crossref","unstructured":"Low PA, Nickander KK: Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes\u200840:873\u2013877, 1991","DOI":"10.2337\/diabetes.40.7.873"},{"key":"2022031216530761800_R185","doi-asserted-by":"crossref","unstructured":"Ziegler D, Reljanovic M, Mehnert H, Gries FA: Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes\u2008107:421\u2013430, 1999","DOI":"10.1055\/s-0029-1212132"},{"key":"2022031216530761800_R186","doi-asserted-by":"crossref","unstructured":"Manzella D, Barbieri M, Ragno E, Paolisso G: Chronic administration of pharmacologic doses of vitamin E improves the cardiac autonomic nervous system in patients with type 2 diabetes. Am J Clin Nutr\u200873:1052\u20131057, 2001","DOI":"10.1093\/ajcn\/73.6.1052"},{"key":"2022031216530761800_R187","doi-asserted-by":"crossref","unstructured":"Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC, Karamitsos DT: Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care\u200820:355\u2013361, 1997","DOI":"10.2337\/diacare.20.3.355"},{"key":"2022031216530761800_R188","doi-asserted-by":"crossref","unstructured":"Malik RA, Williamson S, Abbott C, Carrington AL, Iqbal J, Schady W, et al.: Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial. Lancet\u2008352:1978\u20131981, 1998","DOI":"10.1016\/S0140-6736(98)02478-7"},{"key":"2022031216530761800_R189","doi-asserted-by":"crossref","unstructured":"Ebbehoj E, Poulsen PL, Hansen KW, Knudsen ST, Molgaard H, Mogensen CE: Effects on heart rate variability of metoprolol supplementary to on going ACE-inhibitor treatment in type I diabetic patients with abnormal albuminuria. Diabetologia\u200845:965\u2013975, 2002","DOI":"10.1007\/s00125-002-0869-7"},{"key":"2022031216530761800_R190","doi-asserted-by":"crossref","unstructured":"Singleton JR, Smith AG, Bromberg MB: Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve\u200824:1225\u20131228, 2001","DOI":"10.1002\/mus.1136"},{"key":"2022031216530761800_R191","doi-asserted-by":"crossref","unstructured":"Sochett E, Daneman D: Early diabetes-related complications in children and adolescents with type 1 diabetes: implications for screening and intervention. Endocrinol Metab Clin North Am\u200828:865\u2013882, 1999","DOI":"10.1016\/S0889-8529(05)70106-7"},{"key":"2022031216530761800_R192","doi-asserted-by":"crossref","unstructured":"Howorka K, Pumprla J, Haber P, et al.: Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovascular Res\u200834:206\u2013214, 1997","DOI":"10.1016\/S0008-6363(97)00040-0"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/5\/1553\/592892\/dc0503001553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/26\/5\/1553\/592892\/dc0503001553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T12:32:13Z","timestamp":1647088333000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/26\/5\/1553\/24595\/Diabetic-Autonomic-Neuropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5,1]]},"references-count":193,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.26.5.1553","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5,1]]}}}